FDA Inspection
Amneal Pharmaceuticals Pvt. Ltd.Amneal Pharmaceuticals Pvt. Ltd. – FDA Inspection, Apr 12, 2017
Record Details
This FDA Inspection record concerns Amneal Pharmaceuticals Pvt. Ltd., with an inspection on April 12, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Yumi J. Hiramine (Issuing Officer)
View Company Profile
ID · c21b7ee4-ebdf-44ba-b1ff-965433eddc25
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1011379
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Amneal Pharmaceuticals Pvt. Ltd.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 14, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Amneal Pharmaceuticals Pvt. Ltd.
- FDA Inspection 1216256 - 2023-07-14
- FDA Inspection 1121776 - 2020-02-21
- FDA Inspection 1091111 - 2019-05-24
- FDA Inspection 1067930 - 2018-08-24
- FDA Inspection 1031432 - 2017-09-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.